Regenerex Pharma (RGPX) Non-cash Items (2023 - 2024)
Regenerex Pharma (RGPX) reported Non-cash Items of $38530.0 for Q4 2024, down 46.86% year-over-year from $72501.0 in Q1 2024, and up 54.37% quarter-over-quarter from $24959.0 in Q3 2024.
Regenerex Pharma (RGPX) Non-cash Items (2023 - 2024) Analysis & Trends
Regenerex Pharma (RGPX) has 2 years of Non-cash Items data on file, last reported at $38530.0 in Q4 2024.
- Non-cash Items for Q4 2024 came in at $38530.0, down 46.86% year-over-year; the trailing twelve-month figure through Dec 2024 was $38530.0 (down 46.86% YoY), and the FY2024 annual result was $85132.0, changed N/A from the prior year.
- Non-cash Items climbed to $38530.0 in Q4 2024 per RGPX's latest filing, from $24959.0 in the prior quarter.
- Over five years, Non-cash Items peaked at $85132.0 in Q1 2024 and troughed at $4554.0 in Q2 2023.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 38,530.00 |
| Dec 31, 2024 | 38,530.00 |
| Sep 30, 2024 | 24,959.00 |
| Sep 30, 2024 | 24,959.00 |
| Jun 30, 2024 | 12,561.00 |
| Jun 30, 2024 | 12,561.00 |
| Mar 31, 2024 | 85,132.00 |
| Mar 31, 2024 | 85,132.00 |
| Dec 31, 2023 | 72,501.00 |
| Dec 31, 2023 | 72,501.00 |
| Sep 30, 2023 | 59,691.00 |
| Sep 30, 2023 | 59,691.00 |
| Jun 30, 2023 | 4,554.00 |
| Jun 30, 2023 | 4,554.00 |